Natco Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SALMETEROL XINAFOATE, with a corresponding US DMF Number 18394.
Remarkably, this DMF maintains an Active status since its submission on June 03, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 27, 2015, and payment made on May 08, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II